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Abstract 
The set of proteins required for mitotic division remains poorly characterised. Here, an 
extensive series of correlation analyses of human and mouse transcriptomics data was 
performed to identify genes strongly and reproducibly associated with cells undergoing 
S/G2-M phases of the cell cycle. In so doing, a list of 701 cell cycle-associated genes were 
defined and whilst it was shown that many are only expressed during these phases, the 
expression of others is also driven by alternative promoters. Of this list, 496 genes have known 
cell cycle functions, whereas 205 were assigned as putative cell cycle genes, 53 of which are 
functionally uncharacterised. Among these, 27 were screened for subcellular localisation 
revealing many to be nuclear localised and at least four to be novel centrosomal proteins. 
Furthermore, 10 others inhibited cell proliferation upon siRNA knockdown. This study 
presents the first comprehensive list of human cell cycle proteins, identifying many new 
candidate proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 © The Author 2018. Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, 
IBCB, SIBS, CAS. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction 
in any medium, provided the original work is properly cited. 
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Introduction 
Mitotic cell division is a process common to all eukaryotic organisms and achieved through a 
highly orchestrated series of events classified into four sequential phases: G1 (gap phase), S 
(DNA replication), G2 and M (mitosis). The concerted action of hundreds of proteins is 
required to drive the process through to a successful conclusion, many of which are expressed 
in a phase-specific manner. They mediate processes such as DNA replication and repair, 
chromosome condensation, centrosome duplication and cytokinesis. Dysregulation or mutation 
of genes encoding proteins essential for high fidelity DNA replication, is often associated with 
disease, in particular cancer (Vermeulen et al., 2003; Delaval and Birnbaum, 2007). 
Accordingly, known components of this system are important therapeutic targets (Wiman and 
Zhivotovsky, 2017) and novel components might present new therapeutic opportunities.  
 
Many of the key proteins required for mitotic division are known from studies in model 
organisms including yeast, as well as mammalian cells (Nurse and Thuriaux, 1980; Evans et al., 
1983). With the aim of identifying all the components of the system, high content analysis 
platforms have been utilised. For example RNAi screens (Kittler and Buchholz, 2005; Lents 
and Baldassare, 2006; Neumann et al., 2010), CRISPR/Cas9 (McKinley and Cheeseman, 
2017), proteomics (Dephoure et al., 2008; Pagliuca et al., 2011; Ly et al., 2014) studies have all 
proposed lists of cell cycle genes/proteins but a consensus between studies has not emerged. In 
particular, genome-wide transcriptomics studies (Spellman et al., 1998; Ishida et al., 2001; 
Whitfield et al., 2002; Bar-Joseph et al., 2008; Grant et al., 2013a; Pena-Diaz et al., 2013; 
Dominguez et al., 2016) have identified sets of transcripts sequentially regulated during the cell 
cycle phases in multiple species but comparison of results from four studies of different human 
cell lines identified only 96 genes in common (Grant et al., 2013a). Our reanalysis of these data, 
taking account of some of the technical variables, suggested that the true concordance of the 
cell cycle transcriptional network across cell types is much greater (Giotti et al., 2017). 
Furthermore, our analyses of large collections of tissue and cell transcriptomics data commonly 
identify a large cluster of cell cycle transcripts whose expression is elevated in cells or tissues 
with a high mitotic index (Theocharidis et al., 2009; Mabbott et al., 2010; Balakrishnan et al., 
2013; Doig et al., 2013; Mabbott et al., 2013). 
 
We report here on a data driven curation exercise aimed at identifying the cohort of genes 
up-regulated in all human cell types from the G1/S boundary through to the completion of M 
phase, here after referred to as S/G2-M genes. There are of course, many growth-associated 
transcriptional regulatory events including activation of cyclins, cyclin-dependent kinases, and 
E2F transcription factors, that occur during G1 and are a precondition for entry into S phase 
(Bertoli et al., 2013), but these are not the focus of this study. We monitored genome-wide gene 
expression in primary human dermal fibroblasts (NHDF) cells as they synchronously enter the 
cell cycle from a resting state (G0). Using network co-expression analysis and clustering of the 
data, we identified a cell cycle-enriched cluster associated with the S/G2-M phases. To refine 
this initial list, we identified those genes that were robustly co-expressed when their 
transcription was examined across multiple different human primary cell types in the 
promoter-based FANTOM5 transcriptional data set (Consortium et al., 2014) and in 
synchronised murine fibroblasts. Manual curation of these data resulted in a list of 701 genes 
strongly associated with the S/G2-M phase transcriptional network. Of these, 496 encode 
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proteins with known functions within cell division, 145 of which were not identified in any of 
the previous human cell cycle transcriptomics studies. Of the remaining 205 genes, 53 encode 
functionally uncharacterised proteins. To further validate this discovery set, we examined their 
expression across a range of human tissues and in mouse embryonic tissues during 
development. We also performed functional assays including protein localisation by 
over-expression of GFP-tagged proteins and knockdown by RNAi. 
 
Results 
 
Identification of cell cycle-regulated genes in primary human fibroblasts 
Two time-course microarray experiments were performed on populations of normal human 
dermal fibroblasts (NHDF) synchronised by serum starvation, as used previously for such 
studies (Iyer et al., 1999b; Bar-Joseph et al., 2008). Partial cell synchronisation was confirmed 
by flow cytometric analysis of propidium iodide-stained cells. Following serum starvation 
approximately 40% fewer cells were in the DNA replication phase (S) than in unsynchronised 
populations, and 24 h after the re-addition of serum the number of cells undergoing division had 
increased by 3-4 fold (S and G2-M phases) relative to the starved state (Figure 1A). Data 
derived from two transcriptomics experiments, one monitoring the cells every 6 h for 48 h 
following release from starvation, the second every 2 h over a period of 24 h, were subjected to 
quality control and corrected for batch variation. The datasets were combined and analysed 
together using Graphia
 
Professional, a tool designed to analyse numerical data matrices into 
correlation networks (Freeman et al., 2007). A sample-to-sample correlation network 
confirming the correspondence between the two experiments and time-dependent 
transcriptional changes is shown in Figure 1B.  
 
A gene correlation network (GCN) was then generated using a threshold of r ≥0.88. This value 
is well above the distribution of random correlations (Figure  S1A) and set to minimise the 
number of edges, while retaining a large number of nodes (Figure S1B). After manual removal 
of non-cell cycle related expression modules, MCL clustering (Enright et al., 2002) of the 
network was used to define the main phases of transcription associated with the cell cycle, 
generating 23 gene clusters. The three largest clusters accounted for 96% of the genes 
(probesets): NHDF_C1 (G0; 1,270 nodes, 1176 unique Entrez IDs), NHDF_C2 (G1; 1793 
nodes, 1739 unique IDs), and NHDF_C3 (S/G2-M; 1052 nodes, 963 unique IDs) (Figure 1C). 
The average gene expression profile of the three clusters over the first 24 h following the 
re-addition of serum is shown in Figure 1D. NHDF_C1 comprised of genes induced during the 
starvation period (0 h), but down-regulated soon after the re-addition of serum to the growth 
medium. The average expression of genes within NHDF_C2 peaked around 6 h post-refeeding, 
consistent with gap (growth) phase (G1) (Campisi et al., 1984). NHDF_C3 included genes 
which were induced between 12 and 20 h post re-feeding, many of which remained elevated in 
their expression at later time points. Enrichment analysis performed on each gene cluster 
reported highly significant GO_BP term enrichments for all three clusters, the most significant 
of which are shown in Figure 1E. NHDF_C1 (G0-associated) was highly enriched with genes 
involved in lipid metabolism, such as „lipid metabolic process‟ and „sterol biosynthetic 
process‟, supporting the evidence that these pathways are activated to adjust cellular 
metabolism during the starvation period (Chang et al., 2002) (Figure 1E). NHDF_C2 was 
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enriched in biological processes associated with cell growth, such as „ribosome biogenesis‟, 
„macromolecule metabolic process‟, „cellular component organisation or biogenesis‟, and 
„intracellular transport‟ and included many of the known regulators of G1 including E2F3 and 
CDK6 (Meyerson and Harlow, 1994; Leone et al., 1998). Finally, NHDF_C3 was highly 
enriched with terms such as „chromosome organisation‟, „DNA repair‟, „centrosome 
organisation‟, „telomere organisation‟, „DNA strand elongation‟, „spindle assembly‟, and 
„cytokinesis‟ (Figure 1E). A more granular cluster analysis of this coexpression network (MCLi 
2.2) is presented in Figure S1C and Table S1. We then fragmented NHDF_C3 by applying the 
MCL algorithm with more stringent clustering and highlighted sub-clusters representative of 
G1/S transition, S and G2-M phases (Figure S2A), as they contained many of the cell cycle 
genes known to be induced at those phases. Accordingly, their pattern of expression showed a 
sequential induction beginning at 12-14 h for G1/S related clusters (NHDF_C3c/d), at 18 h for 
the S cluster (NHDF_C3a) and at 20-22 h for the G2-M phase cluster (NHDF_C3b) (Figure 
S2B). Included in the clusters, were many known cell cycle checkpoint genes (as annotated by 
Gene Ontology), which, expectedly, were found overall enriched in the corresponding clusters 
(Figure S2C and Table S1). Many of these genes were annotated as being associated with 
multiple checkpoint pathways, such as CHK1, activated in DNA damage pathways both during 
S phase and at mitosis onset. 
Transcripts within NHDF_C3 plus all nodes immediately adjacent to them (n+1), representing 
1207 unique Entrez IDs, were then selected for further analysis. A more granular cluster 
analysis of this coexpression network (MCLi 2.2) is presented in Figure S1C and Table S2. 
 
Refinement of the core cell cycle gene signature  
To refine the candidate list of NHDF S/G2-M phase-associated genes and eliminate genes that 
may be specific to differentiated fibroblast function, we examined their expression using the 
FANTOM5 consortium promoter level CAGE data (HCF5), derived from more than 100 
different primary human cell types (495 samples) (Consortium et al., 2014). The 1207 genes 
identified in the NHDF data were mapped to the FANTOM5 dataset returning 3,145 promoters 
with expression >5 TPM (tags per million) in at least one sample. These data were subjected to 
network analysis (r >0.5). The graph contained 2889 promoters (nodes) and 175516 edges from 
which the MCL cluster algorithm (MCLi = 1.7) also generated 23 clusters (Figure 2A). 
HCF5_C1 (1,230 promoters of 745 genes) was enriched for cell cycle-associated genes (Figure 
2B). Of the other clusters, only HCF5_C2 exhibited any enrichment for the GO_BP term „cell 
cycle‟ but at a much lower significance (Figure 2B). The average expression of HCF5_C1 gene 
promoters was greatest in highly proliferative cell populations such as embryonic stem cells, 
epithelial cells and a population of CD34
+
 hematopoietic stem cells. In contrast, monocytes 
displayed minimal expression of these genes, reflecting the low rate of proliferation in these 
populations (Swirski et al., 2014) (Figure 2C, top profile). The remaining HCF5 clusters 
contained promoters with a diverse range of expression profiles (Figure 2C). Many genes 
within HCF5_C1 also included alternative promoters (254 genes, 526 promoters) with distinct 
expression profiles that clustered independently (Figure 2D). Highlighted are six genes with 
known functions in the cell cycle, three of which, RFC2, MCM5, and MCM7 encode proteins 
known to be required for DNA replication (Fragkos et al., 2015). The alternative promoters 
were most highly-expressed in immune cell types (Figure 2E). 
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Based upon the merge of the two datasets, the initial list of 963 genes (1052 probesets) 
generated from the analysis of NHDF cells, was reduced to a list of 745 genes with promoters in 
HCF5_C1 from the FANTOM5 data where the expression was tightly correlated across diverse 
human cell populations.  
 
Manual curation of the S/G2-M cell cycle list  
The 745 genes identified above were individually curated. We removed 198 genes that were 
induced late in G1 and in advance of the likely onset of S phase. Conversely, we restored 132 
genes, where the literature or other data (see below) indicated that they function in the cell 
cycle and individual examination of the FANTOM5 data indicated that they were, indeed, 
relatively more highly-expressed in proliferating cells, albeit not included in HCF5_C1.  
   
To examine the inter-species conservation of the S/G-M transcriptional network, an additional 
transcriptomics experiment was performed on synchronised mouse embryonic fibroblasts 
(MEF). The majority of mouse/human orthologues showed a conserved expression pattern 
across the cell cycle (Figure 3A). The transcriptional network of the mouse fibroblast data 
was similar in topology to the NHDF data (Figure S3A-B) and an additional 22 known cell 
cycle genes were observed to co-cluster with the S/G2-M phase genes in these cells.  
 
The merged outcomes of the comparative analysis and manual curation of these data produced 
a set of 701 cell cycle regulated genes (see Table S3). The genes were then assigned to either 
„S‟ or „G2-M‟ phases by correlating them with the expression of known cell cycle 
phase-specific factors: CDC25A and BRCA1 (S phase), and CDK1 and CCNB1 (G2-M phase) 
(Blomberg and Hoffmann, 1999; Xu et al., 2001; Stark and Taylor, 2006). Accordingly, 380 
genes were assigned to S phase and 321 to G2-M phase (Figure S4A). The two sets of 
phase-associated genes were analysed for enrichment of known binding motifs. Both sets 
were significantly enriched with cell cycle transcription factor binding sites. Amongst others, 
S phase genes were shown to be highly enriched for E2F sites (P-value = 1E-59) and the 
G2-M genes for CHR (P-value = 1E-15) and NFY (P-value = 1E-24) sites (for detailed results 
see Figure S4B). Phase annotation was also consistent overall with those of previous cell 
cycle studies (Figure S4C).   
 
After a systematic database and literature-based curation of the gene list, the majority (496) 
were found to be functionally associated with a cell cycle-related process (Figure 3Bi). For 
example, „DNA damage‟ and „DNA replication‟ linked predominantly with S phase annotated 
genes, and „Chromosome partition‟ and „Spindle assembly and regulation‟ being associated 
mainly with G2-M phase (Figure 3Bii). Other categories included a similar number of genes 
induced at either phase, such as „Cell cycle regulation‟. For 205 genes little or no direct 
evidence of a direct involvement in the cell cycle could be found, although in some cases 
there was circumstantial evidence to support this relationship, e.g. publications showing their 
expression to be elevated in cancer. These genes are classified as „putative‟ cell cycle genes. 
Others in this category encode proteins that function within pathways that potentially relate to 
cell division, e.g. apoptosis, whilst the association of yet others would appear more tenuous, 
e.g. RNA processing and immunity. For 53 genes, no functional information was found.  
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There is a significant overlap between our S/G2-M gene list and the cell cycle gene lists 
generated by previous studies (Figure 3Biii). However, the current list showed a greater 
enrichment of genes with the GO_BP term cell cycle when compared with published cell 
cycle lists (Figure 3C). Indeed, many well-validated S/G2-M phase genes (145) were not 
shown to be regulated in any of the previous transcriptomics study, including mitotic 
regulators such as MADL2L2, four members of the augmin complex HAUS1,2,4,7, three 
members of the APC/C cyclosome complex, ANAPC1,7,15, multiple DNA 
replication-dependent histone isoforms (Neumann et al., 2010) and several genes encoding 
components of the centrosome (CEPs) and the nucleopore complex (NUPs) (Figure 3D).  
Conversely, there were 345 genes annotated with the GO_BP term cell cycle identified by at 
least one of the five previous human transcriptomics studies but not the current study. When 
examined in the context of the current NHDF data, many were induced during G1, whereas 
others did not show significant variation in their expression over the cell cycle (Figure S5).  
As noted above, we have deliberately excluded genes that are known to be induced in G1, 
although this gene set may include genes that are essential for cell cycle progression (Bertoli 
et al., 2013).   
  
Table 1 summarises biological processes of the 496 known cell cycle genes along with the 
205 novel putative cell cycle genes. A more detailed spreadsheet of the 701 genes with 
corresponding classifications and evidence supporting their functional association with cell 
cycle can be found in Table S3. In Table S3, genes were ranked by a simple confidence score 
based on available experimental evidence from this and previous studies. 
 
Validation of the S/G2-M transcriptional network using independent data 
To further validate the conservation of co-expression of the S/G2-M gene list, we explored 
two additional datasets. The first was a human tissue expression atlas (HTA) of RNA-seq data 
derived from 95 samples of 27 human tissues (Fagerberg et al., 2014). Of the 701 S/G2-M 
genes defined here, 655 were identified in these data and their co-expression examined. At a 
correlation of r ≥ 0.5, 641 genes were present in the graph, which divided into two 
MCL-defined clusters encompassing 549 genes (Figure 4A). The genes in these clusters were 
expressed widely, with an elevated expression level associated with proliferative tissues 
(Figure 4B). HTA_C1 was comprised of genes whose expression in the testis was higher 
(Figure 4B, top) as compared to the expression of HTA_C2 genes, which showed highest 
expression in bone marrow and lymph node (Figure 4B, bottom). The majority of known 
S/G2-M genes clustered together and significantly, so did the putative cell cycle genes (Figure 
4C-D), supporting their association with this system. A second promoter-level dataset 
produced by the FANTOM consortium (MDF5) (Consortium et al., 2014), comprised of 17 
mouse tissues sampled at multiple intervals during embryogenesis and post-neonatal 
development. Again the data for only the S/G2-M genes (2,141 promoters mapping to 658 
genes) was examined. Similarly, the majority of the promoters/genes co-clustered, with the 
exception of a few small clusters (Figure 4E). In general the promoters in MDF5_C1 
exhibited highest expression in embryonic tissues, their expression markedly decreasing with 
developmental age, a pattern reflecting the reducing rate of proliferation during development 
(Figure 4F, top profile). A notable exception to this was in the case of the spleen and thymus, 
where expression peaked around birth. In line with observations in the human tissue atlas 
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dataset, a portion of S/G2-M genes (MDF5_C2) were predominately expressed in adult testis 
(Figure 4F, middle profile). Multiple smaller clusters, the majority of which were associated 
with alternative promoters of cell cycle-associated genes, exhibited tissue-specific promoter 
expression (Figure 4F, bottom profile). Again putative S/G2-M genes were co-expressed with 
the known cell cycle genes (Figure 4G-H). Co-expression of the S/G2-M genes within the 
context of all genes are shown in Figure S6A-B, for the HTA dataset and in Figure S6C-D for 
the MDF5 dataset. Promoter analysis of the 205 putative cell cycle genes alone showed that 
they were enriched in known S/G2-M transcription factor binding sites, i.e. for E2Fs and 
NFY, further supporting their associated with cell division (Figure S6E). 
 
Experimental corroboration of the uncharacterised S/G2-M genes 
Many gene products required for S/G2-M phase, are localised to specialised cell 
cycle-associated organelles or structures. For example, chromosome segregation during 
mitosis requires formation of kinetochores at centromeres and the correct attachment of 
kinetochores to spindle microtubules emanating from microtubule organising centres, e.g. 
centrioles and centrosomes. Accordingly, we tested the subcellular localisation of 28 
candidate genes by cDNA transfection in HEK293 cells. As positive controls we included 
CENPA, TACC3, DONSON and MGME1 (Piekorz et al., 2002; Foltz et al., 2006; Fuchs et 
al., 2010; Kornblum et al., 2013), the localisation of which were confirmed by these assays 
(Supplementary Data S1). Each ORF was tagged with GFP at both the C- and N-terminals 
(Simpson et al., 2000; Collaboration, 2016). After inspection of the expression of the 56 
protein constructs (two per clone), their subcellular localisation was analysed (Supplementary 
Data S1). As summarised in Figure  5A, nuclear localisation was the most frequently 
observed (15/28) followed by centrosomal-like localisation (11/28) and cytosol (9/28). In 
some instances localisations were congruent with organelles such as the ER, Golgi apparatus, 
vesicles and mitochondria, possibly representing non-specific protein deposits. In around half 
of cases, the C- and N-terminal tagged proteins produced the same localisation (Figure  5A). 
No cases of completely discrepant localisations between the two constructs were observed. 
For the 11 constructs showing centrosomal-like staining, we examined their localisation along 
with centrosomal marker ɣ-tubulin. Of these, C18orf54, C3orf14 and CCDC150 clearly 
co-localised with ɣ-tubulin during different mitotic stages, i.e. prophase, prometaphase and 
metaphase (Figure  5B-D). For the other constructs no clear co-localisation with ɣ-tubulin 
was demonstrated (not shown) which may be explained by peri-centrosomal localisations 
(e.g. in the case of C9orf40, see Supplementary Data S1). Confocal images of all 28 proteins 
screened can be found in Supplementary Data S1.  
 
To examine whether reducing the expression of the novel S/G2-M phase genes affected cell 
proliferation, we tested the effect of mRNA knockdown in human fibroblasts using esiRNAs.  
We achieved around 80% knock-down efficiency in all cases examined (Figure  5E). As a 
positive control, knockdown of cyclin B1 (CCNB1) produced a strong inhibition of cell 
proliferation compared to control esiRNAs (Figure  5F) and transfection had no effect on 
cell viability (Figure  5G). Of the 39 knockdowns of known cell cycle-regulated genes 
tested, twelve (ARHGAP11A, CCNB1, CCNE1, CENPA, CEP85, ESPL1, FAM111A, 
FIGNL1, FOXM1, KIF11, MAD2L1, REEP4) had a significant impact on the rate of cell 
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proliferation. Similarly, of the 22 uncharacterised cell cycles genes 10 (C17orf53, CCDC77, 
DEPDC1B, FAM72B, GSTCD, NEMP1, RIBC2, RPL39L, UBR7, ZNF367) significantly 
inhibited proliferation (Fig. 5E; results of these analyses in Supplementary Data S2). The 
Mitocheck database is a resource listing the cellular phenotypes from a genome-wide 
RNAi-screen of human proteins, recorded by high-throughput live cell imaging (Neumann et 
al., 2010). Of the known gene components listed for which results were available, 136/490 
(27.8%) resulted in one or multiple cell phenotypes pointing to cell cycle defects. Amongst 
the candidate cell cycle genes, 12.8% were associated with a cell cycle phenotype. For 
example, ZNF85 silencing led to abnormal chromosome segregation and mitotic metaphase 
plate congression, knock-down of ZNF90, UBALD2 and CCDC34 led to cell death and 
ZNF738, CCDC150 and ZNF788 knockdowns resulted in abnormalities in the size and shape 
of nuclei. Mitocheck results have been added to the gene list presented in Table S3. Finally, 
ToppGene (Chen et al., 2009) was used to search for phenotypes significantly associated with 
mutations in the S/G2-M genes. In man, 79 phenotypes were identified, the most significant 
of which included embryonic growth defects, e.g. microcephaly, growth retardation and 
various cancers. In mouse, 242 phenotypes were recorded as enriched, the most significant 
were abnormal cell cycle, embryonic lethality and abnormal nuclear morphology, again 
supporting a strong association with cell cycle defects. A full list of the phenotypes enriched 
for this list and the genes associated with them is provided in Table S4. 
 
Discussion 
The cell cycle is perhaps the most fundamental of all biological processes and functional 
orthologues of many of the core components are conserved across species. Curated databases 
list and classify the function of cell cycle components (Ashburner et al., 2000) and place them 
into pathways (Kanehisa, 2002; Fabregat et al., 2016). In every system studied, from yeast to 
man, there are numerous genes required for cell division that are transcriptionally regulated and 
associated with a given phase of the cell cycle (Spellman et al., 1998; Iyer et al., 1999a). It 
could be argued that all genes involved in anabolic processes are cell cycle-related, since an 
increase in cell size is usually a precondition for cell division. Similarly, genes regulating entry 
into the cycle, e.g. growth factors, are often considered to be cell cycle proteins. In the context 
of this work, we use the term to refer only to the set of proteins that are required when a cell 
commits to undergo mitosis (Giotti et al., 2017). Accordingly, we have sought to define the 
core set of cell cycle genes expressed during mammalian S/G2-M, demonstrating them to form 
a highly correlated transcriptional network across tissues and cell types. As a gene signature, 
S/G2-M genes effectively define the mitotic index of a cell population.  
 
The gene expression patterns observed here in fibroblasts were broadly consistent with 
previous studies using the same cell type and synchronisation method (Iyer et al., 1999b; 
Bar-Joseph et al., 2008). However, a wound-healing response, triggered by the serum, may 
confuse efforts to identify cell cycle-related transcripts in fibroblasts (Whitfield et al., 2002). 
To circumvent this issue, we complemented our analysis by examining the co-expression of the 
fibroblast-derived S/G2-M associated genes using the FANTOM5 primary cell atlas 
(Consortium et al., 2014) to remove genes that showed evidence of cell-specificity in their 
expression. These analyses were further refined by comparison to expression studies in 
synchronised mouse fibroblasts and detailed examination of the primary data. The result is a list 
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of 701 S/G2-M-regulated genes, which are highly enriched in relevant GO terms and 
transcription factor binding sites. Based on manual curation of published reports, 496 of these 
genes encode „known‟ cell cycle proteins, many listed as such in annotation databases, e.g. GO 
and UniProtKB. This list partially overlaps with the findings of previous transcriptomics 
studies on human cells but interestingly, transcriptional regulation of 145 of the known S/G2-M 
associated genes was not detected in any of the earlier reports (Whitfield et al., 2002; 
Bar-Joseph et al., 2008; Grant et al., 2013a; Pena-Diaz et al., 2013; Dominguez et al., 2016). 
The majority of previous studies sought to define cell cycle genes as having a wave-like 
expression profile over multiple rounds of cell division, using Fourier transform-based methods 
to identify them. However, cell division in populations of cells rapidly becomes asynchronous, 
and a fraction of them do not commit to a second cycle (Bar-Joseph et al., 2008). In the current 
study, this fact was reflected in the loss of synchrony in the cell cycle gene expression signature 
after 30 hours, consistent with flow cytometric analyses (data not shown). Not only did 
previous studies exclude many bona fide cell cycle genes, the different criteria and analytical 
methods used produced a poor consensus (Grant et al., 2013a). The correlation-based network 
approach used in this study is a more efficient way to identify phase-specific cell cycle genes 
(Giotti et al., 2017).   
 
The strong association of the many putative cell cycle genes identified here was further 
demonstrated by their conserved coexpression across adult human and developing mouse 
tissues. Some of the S/G2-M phase genes we identified have only been validated relatively 
recently. For example, PRR11 (proline rich 11), mutations in which have been associated with 
cancer, was shown to regulate S to G2-M phase transition (Zhang et al., 2015). Links to cancer 
biology also suggests function for two of the three lncRNAs identified by this study, DLEU1&2 
(Morenos et al., 2014; Wang et al., 2017). There are nine genes annotated as being involved in 
apoptosis, a process that can be initiated if a cell fails a mitotic checkpoint. CASP2, long 
considered to be an orphan caspase (Forsberg et al., 2017), is recognised as a key factor in 
driving cell apoptosis (mitotic catastrophe) triggered by mitotic abnormalities, such as defects 
in chromosomes, mitotic spindles, or the cytokinesis apparatus (Dawar et al., 2017; Vitale et 
al., 2017). Other genes within the list await functional validation.   
 
Amongst the 205 putative cell cycle genes, there are 53 complete functional orphans. Fourteen 
of the 27 we tested localised wholly or partially to the nucleus and 11 showed evidence of 
centrosomal localisation, an organelle vital for cell cycle progression (Doxsey et al., 2005). 
Another three, CCDC150, C3of14, and C18orf54 co-localised with ɣ-tubulin (a centrosomal 
marker). A recent study confirmed this localisation for C3orf14 (Gupta et al., 2015). The 
sub-cellular localisations reported here were in many cases also supported by IHC results 
reported by the Human Protein Atlas database (Uhlen et al., 2010; Uhlen et al., 2010) (data 
not shown). RNAi knockdown assays were also performed on a range of known and 
uncharacterised genes from the list. In these assays, 10 of the 22 uncharacterised proteins 
showed differences in the rate of cell proliferation following gene knockdown, suggesting 
non-redundant functions in cell proliferation, with a hit rate slightly higher than the known 
cell cycle genes tested (Figure 5H). Taken together, these validation data suggest that the 
large majority of the novel cell-cycle regulated genes identified here will be found to function 
in some aspect of S/G2-M biology.    
D
ow
nloaded from
 https://academ
ic.oup.com
/jm
cb/advance-article-abstract/doi/10.1093/jm
cb/m
jy063/5188008 by Edinburgh U
niversity user on 19 N
ovem
ber 2018
 10 
 
The FANTOM5 human and mouse promoterome data provide definitive locations for the 
transcription start sites of genes. Of the 701 genes identified here, in the primary cell atlas data 
at least 254 use alternative promoters that drive their expression outside of the context of the 
cell cycle. Among them, three are involved in the assembly of the replisome, namely: MCM5, 
MCM7, and RFC2 (Fragkos et al., 2015), and had significant expression from alternative 
promoters in certain immune-related cell populations. This observation is in accordance with a 
previous report showing that factors of the minichromosome maintenance complex (MCMs), 
including MCM5 and MCM7, were found to be present on the IRF1 promoter in 
STAT1-mediated transcriptional activation, when cells were treated with IFN-y (Snyder et al., 
2005). MCM5, in particular, was shown to directly interact with STAT1 and to be necessary for 
transcriptional activation (DaFonseca et al., 2001). Similar observations were made in the 
analysis of the mouse development time course data, where many bona fide cell cycle proteins 
are strongly expressed in the testis, where they may play a role in meiosis or be part of the 
centrosomal biology associated with flagella. The „moonlighting‟ of cell cycle genes in other 
scenarios also likely breaks up the transcriptional signature in co-expression analyses across 
datasets comparing tissues or cells (Theocharidis et al., 2009; Mabbott et al., 2010; 
Balakrishnan et al., 2013; Doig et al., 2013; Mabbott et al., 2013). These alternative transcripts 
may be regulated in a unique manner to support DNA-dependent processes such as 
recombination, somatic hypermutation and class switching that are unique to leukocytes, or 
other distinct functions. 
 
In summary, this study set out to define the transcriptional network associated with the final 
stages of the human cell cycle, between entry into S phase through to the completion of mitosis. 
The aim was not only to summarise the known components of this system but to identify new 
ones. Through detailed analyses of multiple human and mouse datasets we have defined 701 
genes as being upregulated during the S/G2-M phase of the cell cycle, many of which are 
conserved across species. Based on promoter expression some proteins would appear to 
function exclusively within the context of cell division, others would appear to have additional 
roles outside of this system. Functional assays performed on a number of the uncharacterised 
genes strongly suggests that many are indeed novel components of the cell cycle machinery. 
The gene list provided represents the first comprehensive list of experimentally derived and 
validated S/G2-M phase associated genes. As such this work provides a valuable resource of 
both the known and potentially novel components that make up the many pathways and 
processes associated with mitotic cell division. 
   
Materials and methods  
 
Cell culture and synchronization 
Primary human dermal fibroblasts (NHDF) isolated from neonate foreskins (gifted by Dr Finn 
Grey, University of Edinburgh, UK) were plated on 175 cm
2
 tissue culture flasks (Thermo 
Fisher) at density of 6×10
3
 cells/cm
2
. Cells were cultured in DMEM (Sigma-Aldrich) with 10% 
(v/v) foetal calf serum (FCS) (GE Healthcare) and antibiotics (25 U/ml penicillin and 25 µg/ml 
streptomycin, Life technologies). Starvation-induced synchronisation was achieved by 
replacing full medium with DMEM containing 0.5% FCS for 48 h in accordance with published 
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methods (Brooks, 1976). After this time, medium was replaced with DMEM containing 10% 
FCS promoting the synchronised entry of the NHDF back into the cell cycle. Similarly, mouse 
embryonic fibroblasts (MEF) were cultured in 175 cm
2
 tissue culture flasks (Thermo Fisher) at 
a density of 6,000 cells/cm
2 
in DMEM with 10% FCS and the same protocol followed as for 
NHDF synchronisation.  
 
In both cases, cell synchronisation was assessed after 48 h of serum starvation and at various 
time points following the re-addition of complete medium using a BD LSR Fortessa X-20 flow 
cytometer (BD Biosciences) with propidium iodide staining. Unsynchronised populations were 
evaluated to assess the degree of synchronisation achieved. For protein localisation assays, 
1×10
5 
HEK293T cells were grown in DMEM (Sigma-Aldrich) medium plus 10% FCS, 1% 
Glutamax (Gibco), 1% non-essential amino acids (Gibco) and 25 Units/ml 
penicillin/streptomycin on 13 mm glass coverslips previously coated with poly-L-lysine (0.1 
mg/ml) in each well of a 24-well plate. Cells were grown until coverage of approximately 70% 
was obtained. To increase percentage of cells undergoing mitosis, HEK293 were reversibly 
blocked at the G2/M boundary with RO3306, as described previously (Vassilev, 2006). 
 
Microarray preparation 
Two human microarray datasets were generated using normal human foreskin fibroblasts 
(NHDF). For the first microarray experiment duplicate samples were taken at 6 h intervals over 
a 48 h period (24 samples in total including unsynchronised control cells cultured in parallel 
and harvested at 0 and 24 h). In a second independent experiment, samples were collected at 1 
and 2 h following re-addition of complete medium, and then every 2 h for a 24 h period (16 
samples in total including two control samples). In a third microarray experiment using mouse 
fibroblasts, MEF samples were collected at 0, 0.5, 1, 2 h following re-addition of complete 
medium and then every 2 h for a 30 h period (24 samples in total including replicates for 0, 12, 
18, 24 h samples and unsynchronised control samples). For all experiments described above 
total RNA was isolated using the RNeasy Mini Kit (QIAGEN) according to manufacturer‟s 
instructions. cDNA was generated by the reverse transcription of total RNA (500 ng) using the 
Ambion WT Expression Kit (Life technologies), fragmented and then labelled by TdT DNA 
labelling reagent using GeneChip® WT Terminal Labelling Kit (Affymetrix) according to 
manufacturer‟s instructions. Samples were hybridized to Affymetrix Human Gene 1.1-ST 
Arrays for both NHDF time course experiments and to the Mouse Gene 2.0 ST Arrays for the 
MEF experiment using an Affymetrix GeneAtlas system. Raw data of experiments have been 
submitted to Gene Expression Omnibus repository (GSE104619). For cross-validation the 
Fantom5 (F5) primary cell atlas of human promoter expression (Balakrishnan et al., 2013) was 
used, including 495 samples from about 100 human primary cell types. The data is publicly 
available at http://fantom.gsc.riken.jp/5/ (Lizio et al., 2015). 
 
Data pre-processing 
Raw data (.cel files) derived from the three microarray experiments were pre-processed using 
Bioconductor (www.bioconductor.org). The package ArrayQualityMetrics was used to 
perform QC on the data. All arrays passed the various tests carried out by the package and 
expression levels were normalised using Robust Multiarray Averaging (RMA) normalisation 
using the Oligo package. The two normalised NHDF datasets were also adjusted with the batch 
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correction algorithm ComBat (Johnson et al., 2007) to adjust for variations in the average 
intensity between experiments. Low intensity signal probesets (< 20) were removed (a total of 
9,408 probesets). Likewise, a filtering of low-end signal was applied on the FANTOM5 
primary cell atlas removing promoters with <5 tags per million (TPM) reads. Probe set 
annotations were retrieved with the hugene11transcriptcluser.db package for the human data 
and with mogene20sttranscriptcluster.db package for the mouse data. Mouse to human 
orthologues were retrieved from the web resource Mouse Genome Informatics (MGI) 
(http://www.informatics.jax.org/). 
 
Network analysis 
The NHDF, FANTOM5 (primary cell and mouse development datasets) (Consortium et al., 
2014), Tissue atlas dataset (Fagerberg et al., 2014) and MEF datasets were subjected to 
network-based correlation analyses. Data was loaded into the tool Graphia Professional 
(Kajeka Ltd.) and Pearson correlation matrices were calculated comparing expression profiles 
between individual samples or genes, and these were used as the basis to construct gene 
correlation networks (GCNs) as described previously (Theocharidis et al., 2009). Correlation 
thresholds for all analyses were set to allow minimal contribution of random correlations to the 
analyses. These were based on a comparison of the correlation distributions of the experimental 
datasets vs. permuted measurements from 2000 randomly selected measurements. Values 
selected also minimised the number of edges whilst maintaining a maximum number of nodes 
(Figure S1A). The two NHDF time-course experiments were analysed together. A correlation 
network was constructed using a threshold of r ≥ 0.88 and the graph clustered to identify 
co-expression modules of genes with a broadly similar expression pattern using the MCL 
clustering algorithm (Enright et al., 2002) with the inflation value (which controls the 
granularity clustering) set to 1.3 (MCLi = 1.3). Clusters of genes whose expression varied for 
technical reasons, i.e. profile associated with a batch or experiment, were removed. The 
correlation network of the remaining data comprised of 4,735 nodes (probesets) connected by 
153809 edges. Using different inflation values the network was divided into a few (MCLi 1.3) 
or many (MCLi 2.2) clusters of transcripts. Transcripts within the S/G2-M cluster (cluster 3) 
plus all nodes immediately adjacent to them (n+1), were then selected for further analysis. The 
node walk expansion was to capture a number of similarly expressed genes on the periphery of 
the main cluster. Entrez IDs of the cell cycle-associated transcripts identified in the NHDF data 
were used to subset the FANTOM5 primary cell atlas, prior to network analysis. The subset 
FANTOM5 primary cell atlas data was then parsed at r ≥ 0.5 and clustered at MCLi = 1.7. The 
MEF time-course data was parsed at r ≥ 0.88 and the resultant networks clustered using MCLi = 
2.2. The Tissue Atlas and FANTOM5 mouse development datasets were subset for the curated 
S/G2-M gene list, plotted at r ≥ 0.5, and clustered at MCLi 3.2 and 1.7, respectively. 
 
Assembly of evidence and annotation of the cell cycle ‘parts list’ 
In assembling a list of cell cycle genes we have sought to bring together various sources of 
evidence to support this association. This includes whether they were implicated by the current 
studies of their expression in experiments performed on NHDF, MEF, or human primary cell 
atlas, previous transcriptomics studies on human cells (Whitfield et al., 2002; Bar-Joseph et al., 
2008; Grant et al., 2013b; Peña-Diaz et al., 2013; Pena-Diaz et al., 2013; Dominguez et al., 
2016), the Mitocheck database (Neumann et al., 2010) and human protein atlas (HPA) (Uhlen 
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et al., 2010) resource, and finally, our own functional assays. Furthermore, we examined 
evidence from the literature as well as annotation and pathway resources to provide, where 
possible, a functional grouping and annotation for each gene. This was carried out by retrieving 
UniprotKB biological process terms (UniprotKB keywords) and when none were found for a 
given gene, annotation was supplemented from other sources, namely Gene Ontology (Gene 
Ontology, 2015) and Reactome (Fabregat et al., 2016). These efforts were backed up by 
extensive review of the published literature. The full list of genes with their corresponding 
functional annotation can be found in Table S3. Based on this work, genes were further 
classified based on evidence of their involvement in cell cycle: The „Known‟ group defines 
genes for which there is robust evidence of their involvement in one of the pathways associated 
with the cell cycle, whereas the „Putative‟ group includes genes for which there is little or no 
direct evidence of them being involved in the cell cycle. This group also includes a number of 
functionally uncharacterised genes. Finally, a simple confidence score was used to order the 
cell cycle list based on the weight of evidence supporting a gene‟s involvement in the cell cycle; 
One point was awarded to all genes for each line of evidence supporting their association with 
the cell cycle, i.e. they were identified by the current or five previous human transcriptomics 
studies (Whitfield et al., 2002; Bar-Joseph et al., 2008; Grant et al., 2013b; Pena-Diaz et al., 
2013; Dominguez et al., 2016), their knockdown generated a mitosis-related phenotype in the 
current Mitocheck screen (Neumann et al., 2010) and whether the gene has been associated 
with a cell cycle-related phenotype in human and mouse (Blake et al., 2017; Kohler et al., 
2017).  
 
Gene Ontology and motifs enrichment analysis 
GO enrichment analyses were conducted with the Database for Annotation, Visualization and 
Integrated Discovery (DAVID, v6.8), a web-based tool for Gene Ontology enrichment analysis 
(http://david.abcc.ncifcrf.gov/). Gene sets within the clusters generated by the MCL algorithm 
were analysed for GO_BP terms using the Functional Annotation clustering tool. Motifs 
enrichment analysis was conducted using HOMER (Heinz et al., 2010) through the 
CAGEd-oPOSSUM web tool (Arenillas et al., 2016). Genomic loci of the cell cycle-associated 
promoters were inputted in the software. Enrichments for known motifs were searched between 
1000 bp upstream and 300 bp downstream from the TSS.  
 
RTCA analysis following gene knockdown by RNAi 
NHDF cells were cultured in Dulbecco Modified Eagle Medium (DMEM, Sigma-Aldrich) with 
10% (v/v) foetal bovine serum (FBS, GE Healthcare) and 25 U/ml penicillin and 25 μg/ml 
streptomycin (Life technologies). The xCELLigence (Roche) real time cell analyser (RTCA) 
system was used to monitor the effect of gene knockdown on cell impedance, taken as a proxy 
for cell proliferation. Background impedance for the E-plates 96 (ACEA Biosciences) was 
standardized by the addition of culture medium (DMEM with 10% FBS, 25 U/ml penicillin, 
and 25 μg/ml streptomycin) following the manufacturer‟s instructions. Following trypsination, 
cells were seeded at density of 6,000 cells/cm
2
 in each well of the 96 well E-plates with the 
additional of 100 µl complete medium. Baseline levels of cell impedance index recorded and 24 
h later, esiRNA transfection esiRNAs (Sigma-Aldrich) was performed while plates were 
undocked from the RTCA station. Transfection of esiRNA was carried out using the 
transfection reagent SilenceMag
 
(OZ bioscience). esiRNA was combined with 3.3 µl 
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SilenceMag and 3.0 µl H2O, and then mixed with antibiotic-free medium in a final volume of 
100 µl and a concentration of 50 nM esiRNA per well. Complete medium was then replaced 
with the transfection mix, placed on magnetic plates (OZ bioscience) for 30 min in the 
incubator under the condition of 5% CO2 at 37
o
C. The transfection mix was then replaced with 
200 µl complete medium before placing the plates back to the RTCA system. Cells were then 
incubated monitoring the cell impedance index every 15 min for 200 sweeps in first stage, 30 
min for 200 sweeps in second stage, and continued at 60 min intervals for 100 sweeps in final 
stage. Time series cell impedance indices were extracted at regular time intervals. Negative 
controls were tested across each plate used to screen known (Fabregat et al., 2016) and 
potentially novel cell cycle-associated genes (Doig et al., 2013). At the time of screen a number 
of the known genes were considered uncharacterised. Each assay was based on results gained 
from running three replicate assays per plate, and repeated on three separate runs. The raw 
dataset was exported as a cell impedance (CI) index with rows named by N time points 
(measurement time points at 30 min intervals following the transfection) and columns named 
by well of samples. Statistical analysis of the data was performed using the R package “RTCA” 
to transform cell-impedance values into cell-index growth rate (CIGR) at regular time intervals 
during the measurement time (Zhang et al., 1999). For scoring of the effect of gene silencing- 
induced proliferation arrest, the package “cellHTS2” was used to normalize average CIGR 
across samples (Boutros et al., 2006). 
 
The library of esiRNAs (endoribonuclease-prepared short interfering RNAs, Sigma-Aldrich) 
employed here has been described elsewhere (Kittler et al., 2005; Kittler et al., 2007). Negative 
control esiRNA reagents against sucrose isomaltase (SI), a gene not expressed by fibroblasts 
and collagen 1A2 (COL1A2), a gene expressed by fibroblasts but not associated with cell 
division. All control esiRNA reagents were used in each assay to verify the lack of non-specific 
effects of esiRNA treatment.  
 
Clone preparation 
Entry clones in pDONR223 and containing open reading frames for candidate genes were 
sourced from the ORFeome collection (Collaboration, 2016). First, 50-150 ng of each entry 
clone was combined with 150 ng destination vector pcDNA-DEST47 or pcDNA-DEST53 
(Life technologies) and 2 µl LR Clonase II enzyme mix (Life technologies). The reaction was 
incubated at 25
o
C for 1 h. Next, 1 µl (2 µg/µl) proteinase K was added to terminate the 
reaction, incubating for 10 min at 37
o
C. Then, 2
 
µl of the recombination reaction was added to 
chemically competent DH5α bacterial cells on ice and incubated for 20 min. DH5α cells were 
subjected to heat shock for 45 sec at 42
o
C followed by 2 min on ice. Finally, 1 ml SOC 
medium was added and incubated at 37
o
C with aeration. Cells were centrifuged at 2000 rpm 
and resuspended in 100 µl LB before plating out on LB plates with 100 µg/ml ampicillin. 
Plates were incubated at 37
o
C overnight. 
 
DNA transfection and Confocal Microscopy 
Transfection of HEK293 cells with Gateway destination clones and K2 transfection system 
(Biontex Laboratories) was performed following manufacturer‟s instructions. Following 
optimisation studies, 1 µg of expression plasmid and 2 µl of the transfection reagent were 
diluted in 500 µl in each well (24-well plate). For GFP fluorescence protein imaging, cells were 
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fixed in 4% paraformaldehyde and labelled for 30 min with Texas RedX Phalloidin (1:40) 
(Invitrogen) and then stained for 5 min in 300 nM DAPI. For centrosomal staining, polyclonal 
anti ɣ-tubulin antibody (Sigma-Aldrich) was used. Alternatively, a polyclonal antibody anti 
α-tubulin (Abcam) was used to stain microtubules during the formation of mitotic spindles. 
Fixation was carried out by applying 300 µl of cooled methanol per well for 2 min on ice. Cells 
were washed three times with PBS and then blocked with 5% goat serum (Sigma-Aldrich) and 
0.1% Triton in PBS for 1 h. Primary antibodies were then diluted accordingly in blocking 
solution, applied on coverslips and incubated either overnight at 4
o
C or for 2 h at room 
temperature. Cells were then washed three times for 1 h with PBS. The secondary antibody was 
diluted in blocking solution (1:500), applied on coverslips and incubated for 1-2 h at room 
temperature. Alexa Fluor® 594 raised in donkey anti-rabbit IgG (H+L) (Life Technologies) 
was used as secondary for both primary antibodies, since they were used separately. 
Fluorescence images were captured on a Nikon EC-1 confocal microscope using Nikon EZ-C1 
software. The following laser/filter combinations were used: DAPI nuclear stain (excitation 
405 nm, emission BandPass 460/50 nm), eGFP (excitation 488 nm, emission BandPass 509 
nm) and Texas Red X Phalloidin (Invitrogen) (excitation 543 nm, emission BandPass 605/70 
nm). 
 
Acknowledgement  
We would like to thank Prof. Bill Earnshaw (Wellcome Trust Centre for Cell Biology 
University of Edinburgh) for his encouragement with the work and giving us the benefit of his 
great expertise in all matters associated with the cell cycle. 
 
Funding 
B.G. is a recipient of a Biotechnology and Biological Sciences Research Council (BBSRC) 
funded EastBio studentship (BB/JO1446X/1). T.L. is supported by a Sir Henry Dale 
Fellowship jointly funded by the Wellcome Trust and the Royal Society (206211/Z/17/Z). The 
Wellcome Centre for Cell Biology is funded by Wellcome grant 203149/Z/16/Z. M.W.B., 
D.A.H., and T.C.F. are funded by an Institute Strategic Grant from BBSRC (BB/JO1446X/1). 
 
Competing interests: The authors have no conflict of interest. 
 
Author contributions: B.G., M.W.B., T.R., and S.-H.C. performed the majority of laboratory 
work described here. B.G. and T.C.F. performed the bioinformatics analyses. B.G., T.L., S.W., 
D.A.H., and T.C.F. wrote and edited the manuscript. T.C.F. supervised the project and 
conceived of the idea behind the work.  
 
Figure captions 
 
Figure 1. Network analysis of synchronised human fibroblasts (NHDF). (A) Flow 
cytometry data monitoring fibroblasts entering proliferation after serum refeeding. In control 
samples 76% of cells are in G0/G1 (“unsynchronised”) but following 48 h of serum starvation 
the figure had increased to 85%, whilst the proportion of cells in S/G2-M is decreased. At 24 h 
post-serum 47% of cells were traversing S/G2-M phase (over 3 times greater than starved 
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populations). (B) Sample-to-sample correlation graph where nodes represent individual 
samples. Samples of starved cells (0 h) and early proliferative populations (1-12 h), form 
distinct sub-groupings in the network, with a clear progression from early to late time points. 
Synchrony is lost at later time points, and samples group with unsynchronised populations. (C) 
Correlation graph of the transcriptional network of synchronised fibroblasts from a quiescence 
through to mitosis. The graph divides in three large clusters: NHDF_C1 (yellow) corresponds 
to genes whose expression is greatest in quiescent fibroblasts and decreases during the entry 
into mitosis (G0); NHDF_C2 genes (green) expression is associated with G1, their expression 
peaking between 1 and 8 h after the addition of serum; and the expression of genes in 
NHDF_C3 (red) start to rise from the beginning of the G1/S transition to mitosis. Nodes 
represent individual probesets. (D) Corresponding average expression profiles of genes in 
NHDF_C1-3. (E) GO enrichment analysis on the gene content of the three clusters. 
 
Figure 2. Co-expression of promoters associated with S/G2-M fibroblast genes across the 
FANTOM5 primary cell atlas. (A) Clustered graph representing the promoters of the S/G2-M 
phase associated genes identified in the NHDF data and their correlated expression in the 
context of the FANTOM5 primary cell atlas. Nodes represent individual promoters, their colour 
representing membership to co-expression clusters. (B) GO enrichment analysis for the GO_BP 
term „cell cycle‟ on each of the 23 clusters identified, cluster 1 to be highly enriched in cell 
cycle genes. (C) The expression profile of the HCF5_C1 promoters showed them to be 
transcribed in a wide variety of primary cells with highest expression in embryonic cells and a 
number of epithelial cells, but a relatively low expression in monocytes (top). In contrast other 
clusters, not enriched in cell cycle gene promoters, exhibited a different pattern of expression. 
The average expression of clusters HCF5_C2, 3, and 4 promoters was greatest in immune cell 
populations (middle). Others (bottom) exhibited cell type-specific expression, e.g. hepatocytes 
(HCF5_C7), adipocytes (HCF5_C9), whole blood (HCF5_C12) and melanocytes 
(HCF5_C22). (D) Nodes in the graph shown in A, were color-coded to show differential 
promoter expression. HCF5_C1 (green nodes) is comprised of 1,230 promoters corresponding 
to 745 genes, the red nodes represent an additional 526 promoters associated with 254 of the 
HCF5_C1 genes. (E) Promoter expression profiles of six genes being driven by promoters 
associated with the cell cycle (green profile) and expression of their alternative promoters (red 
profile). 
 
Figure 3. Analysis of the S/G2-M transcriptional network. (A) Heatmaps demonstrate a 
highly conserved pattern of expression between human S/G2-M phase associated genes and 
their 667 mouse orthologues over the first 24 h in human fibroblasts (NHDF) and mouse 
embryonic fibroblasts (MEF) following serum refeeding. Genes were ordered by the phase 
assignation calculated from the NHDF data. (B) CIRCOS plot showing the associations 
between the 701 S/G2-M human genes identified here and (i) the functional category with 
which they have been manually curated to belong. They have been divided as the whether they 
are „known‟ or „putative‟ cell cycle genes. (ii) Edges are coloured based on the phase assigned 
from the NHDF data. (iii) The inner coloured blocks show genes reported by previous human 
cell cycle transcriptomics studies. (C) Histogram of GO enrichment scores for the GO_BP term 
„cell cycle‟ for the current and previously published cell cycle lists. (D) Block diagram showing 
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the functional category assignment of the 145 genes reported in the literature to be cell 
cycle-associated, but undetected by previous transcriptomics cell cycle studies. 
 
Figure 4. Confirmation of coexpression of S/G2-M genes across human and mouse 
tissues. (A) Clustered coexpression network of S/G2-M genes across human tissue atlas 
(HTA). (B) The average expression profile of the genes in the two main clusters is very similar 
with the exception that genes in HTA_C1 are strongly expressed in the testis. (C) Interesting 
both known and putative cell cycle genes cluster together, (D) having very similar expression 
profiles. (D) Clustered coexpression network of promoter level data of mouse orthologues of 
human S/G2-M genes in the mouse development dataset from FANTOM5 (MDF5). Here a 
number of clusters are observed. (F) The largest group (MDF5_C1) are highly expressed in all 
developing tissues but expression levels generally decrease with age. However, in the case of 
spleen and thymus highest levels of express are observed around birth.  MDF5_C2 promoters 
are highly expressed in adult testis and alternative promoters that form the majority of other 
clusters show a variety of tissue-specific expression patterns. (G and H) Promoters for known 
and putative cell cycle genes cluster together and exhibit a similar expression profile. 
 
Figure 5. Subcellular localisation and RNAi assays of candidate cell cycle components. 
(A) Matrix summarising the subcellular localisations of the 28 proteins screened. For a full 
description of these data see Supplementary Data S1. (B-D) C3orf14, CCDC150, and C18orf54 
were found localised on the centrosomes at different stages of mitosis. Proteins are tagged with 
GFP (green), nuclei are stained with DAPI (blue), and centrosomes marked with anti ɣ-tubulin 
antibody (red). Scale bar, 10 µm. (E) Knock-down efficiencies of siRNA against four potential 
novel cell cycle genes measured as the ratio between the silenced gene expression and GAPDH 
expression. (F) Positive control cyclin B (CCNB1) silencing decreased cell impedance index 
(proliferation) compared to negative controls for sucrase-isomaltase (SI) and collagen 1 A2 
(COL1A2). (G) Viability assays after gene knock-down of two known cell cycle regulators 
(CCNB1 and FOXM1) and a negative control (COL1A2) compared to untransfected cells. (H) 
Proliferation profiles following gene knock-down of four uncharacterised but putative cell 
cycle genes RIBC2, ZNF367, C17orf53, and CCDC77 compared to knock down of SI. For a full 
description of the results all knock-down experiments performed here, see Supplementary Data 
S2. 
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Table 1 
Process Genes 
Cell cycle 
regulation 
ATAD2, BORA, BTG3, CASP8AP2, CCDC134, CCNA2, CCNB1, CCNB2, CCNE1, CCNE2, CDC25A, CDC25B, CDC25C, 
CDC5L, CDC7, CDCA3, CDCA4, CDCA7, CDK1, CDK19, CDK4, CDKN2C, CDKN2D, CDKN3, CKS1B, CKS2, CRLF3, 
DBF4B, DLGAP5, E2F1, E2F7, E2F8, FAM83D, FBXO5, FOXM1, FZR1, GMNN, LIN54, LIN9, MASTL, MELK, MYBL2, 
NPAT, ODF2, PA2G4, PBK, PIMREG, PKMYT1, PRR11, RBL1, STIL, TCF19, TFDP1, TICRR, TOE1, TRIM28, TTF2, 
UBE2C, UBE2S, UHRF2, USP37, WEE1, CDK2, AURKA, KIF14, DTL, GTSE1, PLK1 
Chromatin 
organisation 
ANP32B, ANP32E, ASF1B, CHAF1A, CHAF1B, HJURP, SLBP, DNMT1, UHRF1, HIST1H1A, HIST1H1B, HIST1H1C, 
HIST1H1D, HIST1H1E, HIST1H2AB, HIST1H2AC, HIST1H2AE, HIST1H2AG, HIST1H2AH, HIST1H2AI, HIST1H2AJ, 
HIST1H2AK, HIST1H2AL, HIST1H2AM, HIST1H2APS4, HIST1H2BB, HIST1H2BC, HIST1H2BE, HIST1H2BF, 
HIST1H2BG, HIST1H2BH, HIST1H2BI, HIST1H2BJ, HIST1H2BK, HIST1H2BL, HIST1H2BM, HIST1H2BN, HIST1H2BO, 
HIST1H3A, HIST1H3B, HIST1H3C, HIST1H3D, HIST1H3F, HIST1H3G, HIST1H3H, HIST1H3I, HIST1H3J, HIST1H4A, 
HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H2AA4, 
HIST2H2AB, HIST2H2AC, HIST2H2BA, HIST2H2BF, HIST2H3A, HIST2H4B 
Centrosome 
regulation 
ALMS1, CCNF, CCP110, CCT3, CDK5RAP2, CENPJ, CEP120, CEP128, CEP135, CEP152, CEP162, CEP192, CEP295, 
CEP41, CEP44, CEP57, CEP57L1, CEP72, CEP76, CEP78, CEP89, CEP97, CNTLN, CNTROB, FAM161A, KIAA0586, 
KIF24, PLK4, POC5, SASS6, TMEM107, NDE1, POC1A, POC1B 
Cytokinesis ANLN, ARHGAP11A, ASPM, AURKB, CALM3, CEP55, CIT, CKAP2, CNTRL, KIF20A, KIF20B, KIF23, KIF4B, PRC1, 
RACGAP1, INCENP, ECT2, HAUS1, HAUS2, HAUS6 
DNA damage ATAD5, BARD1, DDIAS, DONSON, INTS7, MBD4, MTBP, PARP2, RAD18, RFWD3, RHNO1, RUVBL2, TDP1, TTI1, 
TTI2, PCLAF, DDX11, POLH, LIG1, LIG3, NEIL3, PARP1, RPA1, RPA2, RPA3, POLQ, POLE, DEK, MRE11, RNF168, 
CHEK2, CLSPN, EME1, TIMELESS, TIPIN, MMS22L, PCNA, BRIP1, FIGNL1, HMGB1, HMGB2, INIP, MND1, NSMCE4A, 
NUCKS1, PARPBP, PIF1, PSMC3IP, RAD51, RAD51AP1, RAD51B, RAD51C, RAD54B, RAD54L, RBBP8, SFR1, TSN, 
XRCC2, CHEK1, BRCA1, BRCA2, XRCC1, MCM8, ATRIP, DCLRE1A, EXO5, FANCA, FANCB, FANCC, FANCD2, FANCE, 
FANCG, FANCI, FANCL, FANCM, UBE2T, USP1, SLF1, EXO1, MLH1, MSH2, MSH5, MSH6, POLD2, POLD3, MGME1, 
ATP23, DCLRE1B, MDC1, RIF1, XRCC4, XRCC5, XRCC6 
DNA replication BAZ1B, HAT1, NASP, RMI1, RMI2, RNASEH2A, SSRP1, SUPT16H, RECQL4, BLM, DNA2, POLA1, POLA2, POLD1, 
POLE2, POLE3, PRIM1, PRIM2, PRIMPOL, FEN1, CDC45, MCM10, CDC6, CDT1, MCM3, MCM4, MCM5, MCM6, 
MCM7, ORC1, ORC2, ORC3, ORC5, ORC6, MCMBP, DBF4, FAM111A, GINS1, GINS2, GINS3, GINS4, MCM2, RFC1, 
RFC2, RFC3, RFC4, RFC5, TOPBP1, WDHD1, WRAP53 
DNA metabolism CTPS2, DCK, DCTPP1, DHFR, DTYMK, DUT, GMPS, HPRT1, MTHFD1, NUDT15, PAICS, PFAS, PRPS2, RRM1, RRM2, 
SLC29A1, TK1, TYMS 
Microtubule 
regulation 
CETN3, CKAP5, DIAPH3, KATNAL1, KIF15, KIF18A, KIF18B, KIF22, KIFC1, TACC3, TUBA1B, TUBA1C, TUBB, TUBB3, 
TUBB4B, TUBE1, TUBG1, TUBGCP3, KIF4A, SKA1, SKA2, SKA3, PCNT, NUSAP1, STMN1 
Chromosome 
partition 
BIRC5, BUB1, BUB3, CDCA8, CEP85, CTCF, ESPL1, KIF2C, KNL1, KNSTRN, MIS12, MIS18BP1, MKI67, NEK2, NSL1, 
NUP37, NUP43, OIP5, PTTG1, SGO1, SGO2, TOP2A, GEN1, CDCA2, DSN1 
DNA condensation CDCA5, ESCO2, NCAPD2, NCAPD3, NCAPG, NCAPG2, NCAPH, NCAPH2, SMC2, SMC4, STAG2 
Kinetochore 
formation 
CENPA, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, CENPO, CENPP, CENPQ, CENPT, CENPU, 
CENPW, ITGB3BP, MIS18A, SPDL1, SPICE1, NDC80, NUF2, SPC24, SPC25, NUP107, KNTC1 
Nuclear envelope 
regulation 
LBR, LMNB1, LMNB2, NDC1, NUP133, NUP155, NUP160, NUP188, NUP205, NUP35, NUP50, NUP85, NUP88, 
NUP93, REEP4, SUGT1, TMPO, VRK1 
Spindle assembly 
and regulation 
AUNIP, CCSAP, CKAP2L, GPSM2, HASPIN, KIF11, KPNB1, LRRCC1, NEDD1, PSRC1, RAN, RCC1, SPAG5, TPX2, 
WDR62, HAUS3, HAUS4, HAUS5, HAUS7, HAUS8 
Spindle checkpoint ANAPC1, ANAPC15, ANAPC7, BUB1B, CDC20, CDC23, CDC27, ERCC6L, MAD2L1, MAD2L2, TRIP13, TTK, ZW10, 
ZWILCH 
Other CHTF18, DSCC1, PDS5B, RAD21, SMC1A, SMC3, ACD, CTC1, POT1, TERF1, CENPX 
Function known 
but link to cell 
division not well 
established  
ARL6IP1, BCL2L12, BCLAF1, CASP2, CDCA7L, FAF1, NAE1, TAF9B, DEPDC1B, FGFR1OP, HMMR, MYO19, STRIP2, 
TROAP, ANAPC1P1, ARHGEF39, CCHCR1, LY6K, TTLL12, HMGB3, APOBEC3A_B, SMCHD1, SMYD4, SUZ12, ASH2L, 
BRD8, CBX1, CBX3, CBX5, CTCFL, EZH2, H2AFV, HELLS, KDM4D, METTL4, NAP1L4, NSD2, PHF19, SUV39H1, 
SUV39H2, YEATS4, H2AFX, H2AFZ, RTKN2, DMC1, MNS1, ACYP1, CHAC2, MTFR2, BRI3BP, C4orf46, CIP2A, DLEU1, 
DLEU2, DARS2, FARSB, RPL39L, ALG10, CCT6A, FN3KRP, MANEA, SEPHS1, TMPRSS11B, UBR7, CCT2, CCT4, CCT5, 
LYRM7, PAAF1, DCAF15, G2E3, LRR1, RNF26, RNF5, UBE2G1, UCHL5, ZYG11A, CAPRIN1, CPSF3, DHX9, ERI1, 
EXOSC5, EXOSC8, HNRNPAB, HNRNPF, HNRNPL, LSM2, LSM3, LSM4, POLR2D, POP7, PPIH, RPP30, SAP130, 
THOC3, ANP32A, ARHGAP11B, ARHGAP19, CAMK4, CDKN2AIPNL, CMAHP, IQGAP3, PAQR4, PDE6D, PIGU, 
PPP2R5D, SHCBP1, TRAIP, TRIM59, COPS3, CDK16, PHF7, SPATA5, DEPDC1, HLTF, HNRNPD, MXD3, MYEF2, 
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